EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi

Louise Bendixen, Trine I Jensen, Rasmus O Bak

Molecular Therapy · 2023-07 · 31 (7) · 1920-1937

DOI: 10.1016/j.ymthe.2023.03.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2023-07. Verfasst von Louise Bendixen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Health Authority, Novo Nordisk Fonden, Agnes og Poul Friis Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CRISPR-Cas system is commonly known for its ability to cleave DNA in a programmable manner, which has democratized gene editing and facilitated recent breakthroughs in gene therapy. However, newer iterations of the technology using nuclease-disabled Cas enzymes have spurred a variety of different types of genetic engineering platforms such as transcriptional modulation using the CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) systems. This review introduces the creation of these programmable transcriptional modulators, various methods of delivery utilized for these systems, and recent technological developments. CRISPRa and CRISPRi have also been implemented in genetic screens for interrogating gene function and discovering genes involved in various biological pathways. We describe recent compelling examples of how these tools have become powerful means to unravel genetic networks and uncovering important information about devastating diseases. Finally, we provide an overview of preclinical studies in which transcriptional modulation has been used therapeutically, and we discuss potential future directions of these novel modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingGenetic TestingGenetic EngineeringGene Regulatory Networks

Stichwörter der Autor:innen

CRISPRCRISPRaCRISPRiepigeneticpreclinicalscreentechnologytranscriptional modulation

Autor:innen und Institutionen

  • Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.
  • Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark. Electronic address: bak@biomed.au.dk.

Förderung

  • Danish Health Authority
  • Novo Nordisk Fonden
  • Agnes og Poul Friis Fond
  • Danmarks Frie Forskningsfond
  • European Research Council
  • Independent Research Fund Denmark
  • A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
  • Riisfort Fonden

Zitieren

APA

Bendixen, L., Jensen, T. I., & Bak, R. O. (2023). CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi. Molecular Therapy, 31(7), 1920-1937. https://doi.org/10.1016/j.ymthe.2023.03.024

Vancouver

Bendixen L, Jensen TI, Bak RO. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi. Molecular Therapy. 2023;31(7):1920-1937. doi:10.1016/j.ymthe.2023.03.024

BibTeX
@article{Bendixen2023,
  author = {Bendixen, Louise and Jensen, Trine I and Bak, Rasmus O},
  title = {CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi},
  journal = {Molecular Therapy},
  year = {2023},
  volume = {31},
  number = {7},
  pages = {1920--1937},
  doi = {10.1016/j.ymthe.2023.03.024}
}
Kostenlos starten →